Literature DB >> 14614594

Compensatory increase in ahpC gene expression and its role in protecting Burkholderia pseudomallei against reactive nitrogen intermediates.

Suvit Loprasert1, Ratiboot Sallabhan, Wirongrong Whangsuk, Skorn Mongkolsuk.   

Abstract

In the human pathogen Burkholderia pseudomallei, katG encodes the antioxidant defense enzyme catalase-peroxidase. Interestingly, a B. pseudomallei mutant, disrupted in katG, is hyperresistant to organic hydroperoxide. This hyperresistance is due to the compensatory expression of the alkyl hydroperoxide reductase gene ( ahpC) and depends on a global regulator OxyR. The KatG-deficient mutant is also highly resistant to reactive nitrogen intermediates (RNI). When overproduced, the B. pseudomallei AhpC protein, protected cells against killing by RNI. The levels of resistance to both organic peroxide and RNI returned to those of the wild-type when the katG mutant was complemented with katG. These studies establish the partially overlapping defensive activities of KatG and AhpC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614594     DOI: 10.1007/s00203-003-0621-9

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  19 in total

1.  Genetic and genomic insights into the role of benzoate-catabolic pathway redundancy in Burkholderia xenovorans LB400.

Authors:  V J Denef; J A Klappenbach; M A Patrauchan; C Florizone; J L M Rodrigues; T V Tsoi; W Verstraete; L D Eltis; J M Tiedje
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Growth substrate- and phase-specific expression of biphenyl, benzoate, and C1 metabolic pathways in Burkholderia xenovorans LB400.

Authors:  V J Denef; M A Patrauchan; C Florizone; J Park; T V Tsoi; W Verstraete; J M Tiedje; L D Eltis
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 3.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

4.  Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis.

Authors:  Apichai Tuanyok; Marina Tom; John Dunbar; Donald E Woods
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Compensatory functions of two alkyl hydroperoxide reductases in the oxidative defense system of Legionella pneumophila.

Authors:  Jason J LeBlanc; Ross J Davidson; Paul S Hoffman
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

6.  Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions.

Authors:  Tiffany A Major; Warunya Panmanee; Joel E Mortensen; Larry D Gray; Niel Hoglen; Daniel J Hassett
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

7.  The catalase-peroxidase KatG is required for virulence of Xanthomonas campestris pv. campestris in a host plant by providing protection against low levels of H2O2.

Authors:  Thichakorn Jittawuttipoka; Sarinya Buranajitpakorn; Paiboon Vattanaviboon; Skorn Mongkolsuk
Journal:  J Bacteriol       Date:  2009-09-25       Impact factor: 3.490

Review 8.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

9.  Burkholderia pseudomallei transcriptional adaptation in macrophages.

Authors:  Sylvia Chieng; Laura Carreto; Sheila Nathan
Journal:  BMC Genomics       Date:  2012-07-23       Impact factor: 3.969

10.  Characterization of a salt-induced DhAHP, a gene coding for alkyl hydroperoxide reductase, from the extremely halophilic yeast Debaryomyces hansenii.

Authors:  Hsiu-fung Chao; Yung-fu Yen; Maurice S B Ku
Journal:  BMC Microbiol       Date:  2009-08-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.